Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
173
days
Allogeneic Stem Cell Transplantation—A Salvage Option for High‐Risk Chronic Lymphocytic Leukemia Patients: A 15‐Year Single‐Center Experience
AuthorsNatalia B. Mikhailova; Maria I. Kislova; Maria O. Ivanova; Julia A. Zhuravleva; Elena A. Dmitrieva; Elena V. Kondakova; Anna G. Smirnova; Yana V. Krylova; Olga V. Kudyasheva; Yulia Y. Vlasova; Anastasya V. Beynarovich; Nikita P. Volkov; Ivan S. Moiseev; Eugene A. Nikitin; Alexander D. Kulagin
Affiliations1. R.M.Gorbacheva Research Institute Pavlov University Saint‐Petersburg Russia; 2. Botkin Hospital Moscow Russia
62
days
Targeting a CDH1–TK1–dependent DNA Synthesis Pathway Overcomes Chemoresistance in Acute Myeloid Leukemia
AuthorsXiaomin Feng; Li Huo; Clifford Pang; Zhihang Jiang; Yujuan Xue; Huimin Zeng
Affiliations1. Clinical Research Centre Guangdong Clifford Hospital Guangzhou China; 2. Joe R. and Teresa Lozano Long School of Medicine UT Health San Antonio Mays Cancer Center San Antonio Texas USA; 3. Department of Hematology The First Affiliated Hospital Zhejiang University School of Medicine Hangzhou Zhejiang China; 4. Guangzhou Wellness Stem Cell Research Co. Ltd. Guangzhou China; 5. Department of Gastroenterology The First Affiliated Hospital of Chongqing Medical University Chongqing China; 6. Department of Pediatrics Peking University People's Hospital Peking University Beijing China
217
days
Studying Chronic Lymphocytic Leukemia Microenvironment in the Multi Omics Era
AuthorsBucci Antonella; Notarpietro Giulia; Apollonio Benedetta; Vegliante Maria Carmela; Pappagallo Susanna Anita; Mondelli Paolo; Scattone Anna; Donati Benedetta; Ponzoni Maurilio; Frenquelli Michela; Ghia Paolo; Minoia Carla
Affiliations1. Hematology and Cell Therapy Unit IRCCS Istituto Tumori “Giovanni Paolo II” Bari Italy; 2. Rare Tumors and Melanoma Unit IRCCS Istituto Tumori “Giovanni Paolo II” Bari Italy; 3. Pathology Unit IRCCS Istituto Tumori “Giovanni Paolo II” Bari Italy; 4. Laboratory of Translational Research Azienda Unità Sanitaria Locale—IRCCS di Reggio Emilia Reggio Emilia Italy; 5. Pathology Unit San Raffaele Scientific Institute Milan Italy; 6. Università Vita‐Salute San Raffaele Medical School Milano Italy; 7. IRCCS Ospedale San Raffaele B‐cell Neoplasia Unit Comprehensive Cancer Center Milano Italy
164
days
Defining a Therapeutic Window for Venetoclax in Post‐Transplant Maintenance Therapy for High‐Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes
AuthorsCuicui Lyu; Tianle Xie; Yedi Pu; Xianshuang Luan; Xia Xiao; Mingfeng Zhao; Hairong Lyu
Affiliations1. Department of Hematology Tianjin First Central Hospital Tianjin Thrombosis and Hemostasis Institute Tianjin China; 2. Department of Oncology Xinzhou People's Hospital Xinzhou Shanxi China
314
days
DNA Replication Stress‐Induced Transcriptome of Human Burkitt's Lymphoma Identifies Reciprocal Regulation Between MBD1 and BCL6 During Germinal Center‐Derived B‐Lymphomagenesis
AuthorsSantosh Kumar Gothwal; Kyoko Oichai; Hongtae Kim; Kyungjae Myung; Jacqueline H. Barlow
Affiliations1. Institute of Frontier Science Initiative Kanazawa University Kanazawa Japan; 2. Center for Genomic Integrity Institute for Basic Science Daejeon South Korea; 3. Department of Biochemistry Graduate School of Medicine Tohoku University Sendai Japan; 4. Department of Biological Sciences Ulsan National Institute of Science and Technology Ulsan Korea; 5. Department of Microbiology and Molecular Genetics University of California Davis Davis California USA
224
days
Decoding the Heterogeneity of Diffuse Large B‐Cell Lymphomas: A Comprehensive Genetic, Transcriptomic, and Phenotypic Profiling of B‐Cell Lymphoma Cell Lines
AuthorsMarina Pérez‐Aguilera; Lucía Pedrosa; Sagrario Gómez; Sara Salazar‐Ortego; Ismael Fernández‐Miranda; Rafael Muñoz‐Viana; Paloma Martín‐Acosta; Beatriz L. Martín‐Lunas; Rebeca Jimeno; Natalia Yanguas‐Casás; Beatriz Horcajo; Giovana Roncador; José A. Martínez‐Climent; Ana Ortega‐Molina; Margarita Sánchez‐Beato
Affiliations1. Medical Oncology Department Lymphoma Research Group Hospital Universitario Puerta de Hierro‐Majadahonda IDIPHISA Madrid Spain; 2. Immune System Development and Function Department Metabolism in Cancer and Aging Research Group Centro de Biologia Molecular Severo Ochoa (CBM), CSIC—Universidad Autonoma de Madrid Madrid Spain; 3. Bioinformatics Unit Hospital Universitario Puerta de Hierro‐Majadahonda IDIPHISA Madrid Spain; 4. Pathology Department Cancer Molecular Pathology Group Hospital Puerta de Hierro‐Majadahonda IDIPHISA Madrid Spain; 5. Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES) Madrid Spain; 6. Monoclonal Antibodies Core Unit, Biotechnology Program, Spanish National Cancer Research Centre (CNIO) Madrid Spain; 7. Department of Haematology Center for Applied Medical Research Cancer Center Clinica Universidad de Navarra IDISNA CIBERONC Pamplona Spain
32
days
FLT3‐ITD Measurable Residual Disease in Acute Myeloid Leukemia: Recommended, but Not Yet Self‐Sufficient
AuthorsFrancesco Albano
Affiliations1. Department of Precision and Regenerative Medicine and Ionian Area (DiMePRe‐J)‐Hematology and Stem Cell Transplantation Unit University of Bari “Aldo Moro” Bari Italy
67
days
Early Serum Free Light Chain Response in Newly Diagnosed Multiple Myeloma: Documented Earlier Than MRD and Complementary in Prognosis
AuthorsYubiao Pan; Yue Wang; Yaqin Xiong; Panpan Li; Chenqi Yu; Peng Liu
Affiliations1. Department of Hematology Zhongshan Hospital Fudan University Shanghai China
268
days
A Phase 1 Trial of Duvelisib and Oral Azacitidine in Relapsed/Refractory T‐Cell Lymphoma
AuthorsHayder Saeed; Melanie Mediavilla Varela; Eva Sahakian; Mahrukh Naqvi; Qianxing Mo; Ling Zhang; Rikesh Makanji; Yumeng Zhang; Ning Dong; Leidy Isenalumhe; Sameh Gaballa; Julio Chavez; Bijal Shah; Celeste Bello; Lubomir Sokol; Javier Pinilla‐Ibarz
Affiliations1. Department of Malignant Hematology Moffitt Cancer Center Tampa Florida USA; 2. Department of Biostats and Bioinformatics Moffitt Cancer Center Tampa Florida USA; 3. Department of Pathology Moffitt Cancer Center Tampa Florida USA; 4. Department of Radiology Moffitt Cancer Center Tampa Florida USA
359
days
Longitudinal Monocyte Subset Dynamics as Biomarker in Adult Histiocytosis: Association With Mutational Status, Kinase Inhibitor Exposure and Relapse Risk
AuthorsJerome Razanamahery; Caroline Raymond; Matthias Papo; Francesco Pegoraro; Julien Guy; Ludwig Serge Aho; Jean‐François Emile; Maxime Samson; Sylvain Audia; Julien Haroche; Bernard Bonnotte
Affiliations1. Internal Medicine and Clinical Immunology Department Université Bourgogne Europe CHU Dijon Bourgogne INSERM U1098 Dijon France; 2. Internal Medicine Department Sorbonne Université Assistance Publique Hôpitaux de Paris Pitié‐Salpêtrière Hospital National Reference Center for Histiocytosis Boulogne France; 3. Department of Experimental and Clinical Medicine University of Florence Florence Italy; 4. Hematology Laboratory Université Bourgogne Europe CHU Dijon Bourgogne Dijon France; 5. Department of Epidemiology and Biostatistics Université Bourgogne Europe CHU Dijon Bourgogne Dijon France; 6. Paris‐Saclay University Versailles SQY Assistance‐Publique Hopitaux de Paris Ambroise‐Paré Hospital Smart Imaging Service de Pathology Boulogne France
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days